Anti-CEBP Alpha/CEBPA antibody [EP708Y]
- RabMAb
- Recombinant
- Advanced Validation
- What is this?
4
(2 Reviews)
|
(27 Publications)
Rabbit Recombinant Monoclonal CEBP Alpha/CEBPA antibody. Suitable for ChIC/CUT&RUN-seq, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 27 publications.
View Alternative Names
CEBP, CEBPA, CCAAT/enhancer-binding protein alpha, C/EBP alpha
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)
Overlay histogram showing HeLa cells stained with ab40761 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab40761, 1/100 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)
ab40761 (1/250) staining HeLa cells using immunofluorescence.
- WB
AbReview29648****
Western blot - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)
Blocked with 5% Milk for 1 hour at 24°C.
We are unsure as to the identity of the 30kda band.
All lanes:
Western blot - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (ab40761) at 1/5000 dilution
All lanes:
Human MCF-7 whole cell lysate at 100000 Cells
Secondary
All lanes:
HRP-conjugated Donkey anti-rabbit IgG polyclonal at 1/2000 dilution
Predicted band size: 38 kDa
Observed band size: 40 kDa
true
Exposure time: 1min
This image is courtesy of an anonymous Abreview
- WB
Unknown
Western blot - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)
We are unsure as to the identity of the 30kda band.
All lanes:
Western blot - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (ab40761) at 1/1000 dilution
All lanes:
U937 + LPS cell lysate at 10 µg
Predicted band size: 38 kDa
Observed band size: 30 kDa,43 kDa
false
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 THP-1 (human monocytic leukemia monocyte) cells and 5 µg of ab40761 [EP708Y]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 THP-1 (human monocytic leukemia monocyte) cells and 5 µg of ab40761 [EP708Y]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) method
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 THP-1 (human monocytic leukemia monocyte) cells and 5 µg of ab40761 [EP708Y]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
Related conjugates and formulations (1)
-
Anti-CEBP Alpha/CEBPA antibody [EP708Y] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CEBP Alpha regulates important cellular processes by acting as a transcriptional regulator. It participates in the control of cellular differentiation proliferation and metabolism. CEBP Alpha forms homo- or heterodimers with other proteins of the CEBP family to exert its functions. It induces expression of genes involved in differentiation of myeloid progenitors into granulocytes and macrophages. The protein also promotes adipogenesis by activating genes responsible for the development and function of adipocytes.
Pathways
CEBP Alpha participates actively in signaling pathways that involve cell cycle control and hematopoiesis. In the hematopoietic pathway CEBP Alpha influences the differentiation of progenitor cells into mature blood cells. Additionally it interacts with other proteins such as PU.1 an important regulator in the myeloid lineage and through the MAPK pathway influences growth arrest and differentiation responses. These interactions highlight its essential role in maintaining the balance between cell proliferation and differentiation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (27)
Recent publications for all applications. Explore the full list and refine your search
Cell death discovery 11:166 PubMed40216750
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of orthopaedic surgery and research 20:260 PubMed40069718
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports methods 4:100778 PubMed38749443
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cells 13: PubMed38667324
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 28: PubMed37449516
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed36361730
2022
Applications
Unspecified application
Species
Unspecified reactive species
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 55:e11741 PubMed35976267
2022
Applications
Unspecified application
Species
Unspecified reactive species
Organogenesis 18:2061263 PubMed35435152
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2021:8528239 PubMed34725565
2021
Applications
Unspecified application
Species
Unspecified reactive species
Aging 13:18257-18273 PubMed34311444
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com